Hemispherx Biopharma To Present At 8th International IACFS Conference On Chronic Fatigue Syndrome, Fibromyalgia, Related Illnesses; Successful Transfer Of Technology To Expand Drug Production Announced

PHILADELPHIA--(BUSINESS WIRE)--Sept. 21, 2006--Hemispherx Biopharma, Inc. (AMEX: HEB) announced that William A. Carter, MD, Chairman & CEO, will present at the 8th International IACFS Conference on Chronic Fatigue Syndrome, Fibromyalgia and other Related Illnesses in Fort Lauderdale. Fla., January 10-14. Dr. Carter’s presentation will be based on the submitted abstract “Meta-analysis of Well-controlled Randomized, Double-blinded, Phase II / III Clinical Trials of Poly I : Poly C12U vs. Placebo in Chronic Fatigue Syndrome.”